Ligand validation:1FZO

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1FZO_MRD_A_701	20%	53%	0.175	0.776	1.35	0.49	2	-	8	0	100%	1
1FZM_MRD_A_701	58%	56%	0.135	0.912	1.26	0.46	2	-	1	0	100%	1
1LK2_MRD_B_401	57%	53%	0.125	0.898	0.47	1.31	-	2	1	1	100%	1
1FZK_MRD_A_701	29%	58%	0.186	0.843	1.09	0.55	-	-	0	0	100%	1
5SZD_MRD_A_102	98%	93%	0.06	0.984	0.3	0.17	-	-	0	0	100%	1
4DUI_MRD_A_202	98%	59%	0.06	0.982	0.8	0.79	-	-	0	0	100%	1
1SWU_MRD_A_1	97%	67%	0.05	0.967	0.44	0.83	-	1	0	0	100%	1
7EK9_MRD_A_201	97%	88%	0.06	0.977	0.29	0.38	-	-	0	0	100%	1
6B6R_MRD_A_307	97%	70%	0.068	0.985	0.56	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.